GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinotherapeutics Inc (SHSE:688247) » Definitions » YoY EBITDA Growth

Sinotherapeutics (SHSE:688247) YoY EBITDA Growth : 190.00% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sinotherapeutics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Sinotherapeutics's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 190.00%.

Sinotherapeutics's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.06.


Sinotherapeutics YoY EBITDA Growth Historical Data

The historical data trend for Sinotherapeutics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinotherapeutics YoY EBITDA Growth Chart

Sinotherapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial 124.24 2,243.75 14.93 -31.79 -35.37

Sinotherapeutics Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.29 -40.00 -9.68 -43.10 190.00

Sinotherapeutics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Sinotherapeutics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.19-0.294)/ | 0.294 |
=-35.37 %

Sinotherapeutics's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(0.058-0.02)/ | 0.02 |
=190.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinotherapeutics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Sinotherapeutics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinotherapeutics (SHSE:688247) Business Description

Traded in Other Exchanges
N/A
Address
No. 515 Huanke Road, Room 205 and 207, Pilot Free Trade Zone, Shanghai, CHN, 201203
Sinotherapeutics Inc is engaged in the research and development, production and sales of generic drugs and CRO services.

Sinotherapeutics (SHSE:688247) Headlines

No Headlines